The Effect of Uric Acid and Albumin Ratio in Undergoing Lower Extremity Endovascular İnterventions For Peripheral Arterial Disease Related Contrast Induced Nephropathy.

Serum uric acid/albumin ratio peripheral artery disease post-contrast acute kidney injury

Journal

Annals of vascular surgery
ISSN: 1615-5947
Titre abrégé: Ann Vasc Surg
Pays: Netherlands
ID NLM: 8703941

Informations de publication

Date de publication:
13 Jul 2024
Historique:
received: 29 03 2024
revised: 04 05 2024
accepted: 06 05 2024
medline: 16 7 2024
pubmed: 16 7 2024
entrez: 15 7 2024
Statut: aheadofprint

Résumé

Among patients undergoing percutaneous vascular intervention, contrast-induced nephropathy (CIN) is associated with increased morbidity and mortality.Serum uric acid/albumin ratio (UAR) has emerged as a new marker associated with poor cardiovascular outcomes. We aimed to evaluate the relationship between UAR and CIN occurrence in patients treated for peripheral artery disease. Patients underwent percutaneous intervention due to peripheral artery disease were enrolled. The primary endpoint was development of contrast related nephropathy. Patients were divided into two groups according to the CIN occurrence. 663 patients were enrolled and mean age was 62±10 years. After the intervention, 45 patients had CIN and 618 patients did not have CIN. Logistic regression analysis were performed to define the parameters of CIN. Male gender, diabetes, uric acid /albumin ratio, contrast volume, presence of coronary artery disease and CRP levels were found significant in univariate analysis. However, only UAR was found significant in multivariate analysis (OR 95% CI: 3.426 (1.059-11.079), (p=0.040)).Therefore ,it is the only independent predictor for occurrence of CIN. UAR is a reliable scoring system, which predicts CIN in such patient group. This score is not only cost-effective also simple, which can be easily applied into the clinical practice.

Identifiants

pubmed: 39009115
pii: S0890-5096(24)00419-9
doi: 10.1016/j.avsg.2024.05.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Auteurs

Gökhan Demirci (G)

Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey. Electronic address: gkhncardio@gmail.com.

Ahmet Anıl Şahin (AA)

Department of Cardiology, Istınye University, Liv Bahcesehir Hospital, İstanbul, Turkey.

Mehmet Altunova (M)

Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.

Tuğba Aktemur (T)

Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.

Sezgin Atmaca (S)

Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.

Ahmet Arif Yalçın (AA)

Department of Cardiology, University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Training and Research Hospital, İstanbul, Turkey.

Classifications MeSH